Coronin 1C promotes triple-negative breast cancer invasiveness through regulation of MT1-MMP traffic and invadopodia function by Castagnino, Alessia et al.
HAL Id: hal-02377262
https://hal.archives-ouvertes.fr/hal-02377262
Submitted on 23 Nov 2019
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Coronin 1C promotes triple-negative breast cancer
invasiveness through regulation of MT1-MMP traffic
and invadopodia function
Alessia Castagnino, Antonio Castro-Castro, Marie Irondelle, Alan Guichard,
Catalina Lodillinsky, Laetitia Fuhrmann, Sophie Vacher, Sonia
Agüera-González, Anna Zagryazhskaya-Masson, Maryse Romao, et al.
To cite this version:
Alessia Castagnino, Antonio Castro-Castro, Marie Irondelle, Alan Guichard, Catalina Lodillinsky, et
al.. Coronin 1C promotes triple-negative breast cancer invasiveness through regulation of MT1-MMP
traffic and invadopodia function. Oncogene, Nature Publishing Group, 2018, 37 (50), pp.6425-6441.
￿10.1038/s41388-018-0422-x￿. ￿hal-02377262￿
 1
Coronin 1C promotes triple-negative breast cancer invasiveness through 1 
regulation of MT1-MMP traffic and invadopodia function 2 
Alessia Castagnino 1, Antonio Castro-Castro 1, Marie Irondelle 1,2, Alan Guichard 1, 3 
Catalina Lodillinsky 1,3,4, Laetitia Fuhrmann 5, Sophie Vacher 6, Sonia Agüera-4 
González 1, Anna Zagryazhskaya-Masson 1, Maryse Romao 7, Carole El Kesrouani 5, 5 
Angelika A. Noegel 8, Thierry Dubois 9, Graça Raposo 7, James E. Bear 10, Christoph 6 
S. Clemen 11,8, Anne Vincent-Salomon 5, Ivan Bièche 6,12 and Philippe Chavrier 1,* 7 
1 Institut Curie, PSL Research University, CNRS UMR144, Membrane and 8 
Cytoskeleton Dynamics group, 26 rue d’Ulm, F-75005, Paris, France 9 
2 Institut Curie, PSL Research University, Cell and Tissue Imaging Facility (PICT-10 
IBiSA), 26 rue d’Ulm, F-75005, Paris, France 11 
3 Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología A. H. 12 
Roffo. Área de Investigación. San Martin 5481, Buenos Aires C1417DTB, Argentina 13 
4 Member of Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), 14 
Argentina 15 
5 Institut Curie, PSL Research University, Pathology-Genetics-Immunology 16 
Department, 26 rue d’Ulm, F-75005, Paris, France 17 
6 Institut Curie, PSL Research University, Pharmacogenomic Unit, Department of 18 
Genetics, 26 rue d’Ulm, F-75005, Paris, France 19 
7 Institut Curie, PSL Research University, CNRS UMR144, Biogenesis and Functions 20 
of Lysosome-Related Organelles group, 26 rue d’Ulm, F-75005, Paris, France 21 
 2
8 Center for Biochemistry, Institute of Biochemistry I, Medical Faculty, University of 22 
Cologne, Joseph-Stelzmann-Str. 52, 50931 Cologne, Germany 23 
9 Institut Curie, PSL Research University, Translational Research Department, Breast 24 
Cancer Biology Group, Paris, France 25 
10 UNC Lineberger Comprehensive Cancer Center and the Department of Cell 26 
Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, 27 
NC 27599, USA 28 
11 Department of Neurology, Heimer Institute for Muscle Research, University 29 
Hospital Bergmannsheil, Ruhr-University Bochum, Bürkle-de-la-Camp-Platz 1, 44789 30 
Bochum, Germany 31 
12 EA7331, Paris Descartes University, Sorbonne Paris Cité, Faculty of 32 
Pharmaceutical and Biological Sciences, 4 avenue de l’observatoire, F-75006, Paris, 33 
France 34 
 35 
Conflict of interest disclosure statement: Authors have no conflict of interest to 36 
declare. 37 
 38 
Running title: Coronin 1C regulates breast cancer invasion 39 
Keywords: Coronin 1C, MT1-MMP traffic, invadopodia, breast cancer, invasion 40 
corresponding author: Philippe Chavrier, Institut Curie, CNRS UMR144, 26 rue 41 
d’Ulm, F-75005, Paris, France. Phone: +33156246359, e-mail: 42 
philippe.chavrier@curie.fr  43 
 3
Abstract 44 
Membrane type 1-matrix metalloproteinase (MT1-MMP), a membrane-tethered 45 
protease, is key for matrix breakdown during cancer invasion and metastasis. 46 
Assembly of branched actin networks by the Arp2/3 complex is required for MT1-47 
MMP traffic and formation of matrix-degradative invadopodia. Contrasting with the 48 
well-established role of actin filament branching factor cortactin in invadopodia 49 
function during cancer cell invasion, the contribution of coronin-family debranching 50 
factors to invadopodia-based matrix remodeling is not known. Here, we investigated 51 
the contribution of coronin 1C to the invasive potential of breast cancer cells. We 52 
report that expression of coronin 1C is elevated in invasive human breast cancers, 53 
correlates positively with MT1-MMP expression in relation with increased metastatic 54 
risk and is a new independent prognostic factor in breast cancer. We provide 55 
evidence that, akin to cortactin, coronin 1C is required for invadopodia formation and 56 
matrix degradation by breast cancer cells lines and for 3D collagen invasion by 57 
multicellular spheroids. Using intravital imaging of orthotopic human breast tumor 58 
xenografts, we find that coronin 1C accumulates in structures forming in association 59 
with collagen fibrils in the tumor microenvironment. Moreover, we establish the role of 60 
coronin 1C in the regulation of positioning and trafficking of MT1-MMP-positive 61 
endolysosomes. These results identify coronin 1C as a novel player of the multi-62 
faceted mechanism responsible for invadopodia formation, MT1-MMP surface 63 
exposure and invasiveness in breast cancer cells.  64 
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Introduction 65 
Tumor cell escape and dissemination to distant sites are hallmarks of metastasis, the 66 
leading cause of cancer-related death. During breast cancer progression, a key step 67 
is the transition from ductal carcinoma in situ (DCIS) - a mass of proliferative cells 68 
inside the mammary duct surrounded by an intact myoepithelium and by the 69 
basement membrane (BM) - to invasive breast cancers. DCIS-to-invasive breast 70 
cancer transition is associated with breakdown of the myoepithelium and the 71 
underlying BM and increased metastasis risk. The capacity of cancer cells to remodel 72 
extracellular matrix (ECM) barriers is essential for cancer progression and metastasis 73 
1. Proteolytic remodeling of ECM components by cancer cells mobilizes a group of 74 
transmembrane matrix metalloproteinases (MMPs), which includes membrane type 1 75 
(MT1)-MMP (aka MMP14) 1. We recently reported that MT1-MMP is up-regulated in 76 
invasive hormone receptor- and epidermal growth factor receptor 2 (HER2)-negative 77 
triple-negative breast cancers (TNBCs) as compared to DCIS lesions and normal 78 
breast tissue and overexpression predicts the invasive potential of cancerous lesions 79 
2. 80 
Experimental data based on cancer cell models revealed that ECM remodeling by 81 
carcinomatous cells is focused to the pericellular zone 3, 4. Matrix gaps and tunnels 82 
forming overtime support infiltrating cell passage through the BM and through the 83 
fibrous collagen microenvironment 3. ECM breakdown is mediated by specialized 84 
cellular structures of metastatic cells called invadopodia, which form at the plasma 85 
membrane in association with ECM fibrils and require actin assembly for their 86 
formation 5. Invadopodia are the sites of surface exposure and accumulation of MT1-87 
MMP 6-8. Due to difficulties inherent to the submicrometric size and transient nature 88 
of invadopodia, fewer studies addressed their formation, dynamics and structure in 89 
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vivo. However, recent work based on emerging intravital microscopy technics, 90 
reported the existence of invadopodia-like protrusions in relation with matrix 91 
remodeling and metastasis in the natural tumor microenvironment 9, 10. 92 
Polymerization of invadopodial actin is a multistep process that requires activation of 93 
the Arp2/3 complex by nucleation promoting factor (NPF) Wiskott–Aldrich syndrome 94 
like protein (N-WASP) 11. Regulators of branched actin network dynamics including 95 
cortactin (CTTN) and cofilin are likewise essential for invadopodia formation 6, 12. The 96 
actin-binding protein CTTN promotes actin network assembly by facilitating N-WASP 97 
displacement from Arp2/3 complex and stabilizing Arp2/3 complex at branches 13, 14. 98 
Moreover, CTTN promotes branch stabilization by antagonizing members of the 99 
WD40 domain-containing F-actin binding coronin family members, which control 100 
debranching and Arp2/3-nucleated filament network disassembly 15-17. Additionally, 101 
coronins bind to and inhibit nucleation by the Arp2/3 complex 15, 18, 19. All together, 102 
these data point to some coordinated functions of CTTN and coronin in the regulation 103 
of branched actin network assembly and dynamics. 104 
In carcinoma cells, altered phosphorylation and up-regulation of CTTN are 105 
associated with increased invadopodia density, promoting invasion and tumor 106 
aggressiveness 12, 20-24. Similarly, the coronin-family protein coronin 1C (CORO1C 107 
aka coronin-3, CRN2) is up-regulated in human cancers including gastric cancers, 108 
hepatocellular carcinomas and brain tumors and is correlated with increased 109 
invasiveness and metastasis 24-28. In addition, experimental data have shown that 110 
CORO1C is required for degradation of gelatin as a matrix mimic and for formation of 111 
invasive protrusions by human glioblastoma cells 28, 29. 112 
Convergent observations in carcinoma cell lines have identified a pathway involving 113 
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late endosome (LE)/lysosome compartments in returning internalized MT1-MMP to 114 
invadopodia forming at plasma membrane/ECM contact sites 7, 8, 23, 30-32. Docking of 115 
MT1-MMP-positive LE/lysosomes to the invadopodial plasma membrane allows 116 
surface exposure of the protease possibly through the formation of tubular 117 
connections between the limiting membrane of LE/lysosomes and the plasma 118 
membrane 8, 32, 33. The pathological relevance of this recycling circuitry has been 119 
recently established in the context of the invasion program of TNBCs 23, 31, 32. A 120 
characteristic feature of this mechanism is the presence of F-actin/CTTN-enriched 121 
puncta on MT1-MMP-positive LE/lysosomes, which depend on the Arp2/3 complex 122 
and its activator WASH complex for their formation 8, 23, 34, 35. Perturbation of WASH 123 
function affects endolysosomal F-actin/CTTN puncta, interferes with the trafficking of 124 
MT1-MMP vesicles to the invadopodial plasma membrane and inhibits MT1-MMP 125 
surface exposure and invasion 8, 32. Interestingly, a study in macrophages has 126 
provided evidence for a role of coronin 1A (CORO1A) in controlling endolysosomal 127 
actin assembly in the context of cholesterol trafficking and clearance 36. In addition, 128 
coordinated functions of CTTN and coronin 1B (CORO1B aka coronin-2) have been 129 
implicated in trafficking and plasma membrane docking of multivesicular LEs and 130 
regulation of exosome secretion from these compartments in conjunction with the 131 
small GTPase Rab27a function 37, 38. All together, these data suggest some 132 
cooperative functions of CTTN and coronins in the regulation of endolysosomal actin 133 
dynamics and trafficking and exocytosis of LE/lysosomal cargo proteins including 134 
MT1-MMP. 135 
Here we show that CORO1C is up-regulated in invasive breast cancers and 136 
correlates positively with MT1-MMP expression in TNBCs in relation with poor 137 
prognosis. Additionally, our results indicate that CORO1C plays a dual function in 138 
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MT1-MMP-dependent pericellular matrix degradation by regulating invadopodia 139 
formation and by controlling the positioning of MT1-MMP storage endolysosomes.140 
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Results 141 
CORO1C is associated with poor outcome in breast cancer. Expression of 142 
CORO1A, -B and -C type I coronin family members and pro-invasive MT1-MMP was 143 
analyzed by immunoblotting in a panel of 30 breast cancer cell lines. These cell lines 144 
were stratified in Normal-like, Luminal, TNBC and HER2+ subtypes based on the 145 
expression patterns of estrogen and progesterone receptors (ER and PR) and HER2 146 
amplification 39. Expression of hematopoietic-specific CORO1A was detected in 147 
Jurkat leukemic T-cells while levels were low to barely detectable in the breast 148 
cancer cell lines (Fig. 1AB). In contrast, CORO1B expression was detected in most 149 
breast cancer cell lines irrespective of subtypes (Fig. 1A and C). Expression of 150 
CORO1C was mostly restricted to TNBC cells similar to MT1-MMP expression 151 
pattern (Fig. 1A and DE). Expression of CORO1B and CORO1C mRNAs was 152 
analyzed by quantitative RT-PCR in invasive breast cancers using a retrospective 153 
cohort of 446 patients with long-term follow-up. It allowed us to examine if variations 154 
in CORO1B and -C mRNA expression had a value for patient prognosis (Table S3). 155 
We found that 12.1% of breast tumors overexpressed CORO1B mRNA (>3 relative to 156 
normal tissues, not shown). Highest CORO1B expression levels were observed in 157 
HER2 tumors and positively correlated with Ki-67 proliferation marker (Table S4). 158 
However, we did not see an impact of CORO1B expression on the metastasis-free 159 
survival (MFS) of breast cancer patients (not shown). 160 
Tumors expressing high levels of CORO1C showed more often ER and PR 161 
negativity, correlated with high Ki-67 and epidermal growth factor receptor (EGFR) 162 
levels and were more frequently of an advanced grade indicative of an association 163 
with bad prognosis (Table S5). Most importantly, CORO1C up-regulation was 164 
associated with significantly shorter MFS (Fig. 1F). Multivariate analysis using a Cox 165 
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proportional hazard model revealed independent predictive value for MFS of lymph 166 
node status, tumor size and grade and CORO1C mRNA expression parameters, 167 
indicating that CORO1C expression is a new independent prognostic factor in breast 168 
cancer (Table S6, P=0.0029). 169 
Based on available RT-qPCR data in the same cohort 2, we found a strong positive 170 
correlation of CORO1C and MT1-MMP mRNAs (Fig. 1G). Correlation of CORO1C 171 
and MT1-MMP expression was similarly observed at the protein level by 172 
immunoblotting analysis of a subset of tumor samples selected based on low and 173 
high mRNA levels; while there was no obvious correlation with CORO1B or CTTN 174 
expression in these tumor samples (Fig. S1AB). Importantly, we analyzed the 175 
association of CORO1C and MT1-MMP transcript levels with clinical outcome and 176 
found significantly increased metastatic risk in patients with both high MT1-MMP and 177 
CORO1C mRNA levels (Fig. 1H). The prognostic significance of ‘MT1-MMP and 178 
CORO1C expression level’ persisted in Cox multivariate regression analysis (Table 179 
S7, P=0.00007). 180 
Next, we focused our study on CORO1C showing strongest correlation with pro-181 
invasive MT1-MMP and previously implicated in cancer progression and metastasis 182 
25, 26, 28. Changes in CORO1C protein levels in epithelial cancer cells were 183 
investigated by immunohistochemistry (IHC) analysis of a tissue microarray (TMA) of 184 
invasive breast cancers and adjacent peritumoral tissues from an independent cohort 185 
of 136 patients (Table S8). Specificity of CORO1C IHC staining was established by 186 
analysis of human MCF10DCIS.com breast cancer-derived cells knocked down for 187 
CORO1C expression (Fig. S1C). In peritumoral epithelial tissues, we detected low 188 
cytoplasmic levels of CORO1C in luminal cells and strong expression in 189 
myoepithelial cells (Fig. 2AB). CORO1C staining was observed in the cytoplasm of 190 
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breast carcinoma cells (Fig. 2AB). Quantification and analysis of CORO1C H-score 191 
(intensity multiplied by percentage of positively stained cells) revealed significantly 192 
higher levels of CORO1C in invasive cancer relative to normal breast tissues (Fig. 193 
2C), in agreement with RNA expression data (Table S5) and protein analysis in 194 
breast cancer cell lines (Fig. 1A and D). CORO1C levels were highest in TNBC 195 
subtype although difference with other subtypes was not statistically significant (Fig. 196 
2D). Therefore we concluded that CORO1C expression was up-regulated in invasive 197 
breast cancers at the mRNA and protein levels, particularly in TNBCs and correlated 198 
with worse prognosis and increased metastasis risk in association with MT1-MMP 199 
up-regulation. At the mechanistic level, these data suggested some involvement of 200 
CORO1C in MT1-MMP-dependent pericellular ECM proteolysis activity during breast 201 
tumor progression and dissemination. 202 
CORO1C is required for invadopodia function and tumor cell invasion. 203 
GFPCORO1C was stably overexpressed in MDA-MB-231 cells used as a TNBC model 204 
(Fig. S2A). These cells invaded through the 3D fibrous type I collagen network with 205 
an elongated morphology typical of this highly invasive mesenchymal cell line (Fig. 206 
3A, low magnification inset and Supplementary Movie S1). CTTN and GFPCORO1C 207 
co-localized in lamellipodia at the edge of invasive protrusions extending within the 208 
collagen gel (Fig. 3A, low magnification inset). In addition, arc-shape structures 209 
enriched for CTTN and CORO1C were visible in association with collagen fibrils in 210 
front of the nucleus, which was located at the rear of the cell (Fig. 3A, inset 1). Strong 211 
pericellular collagenolysis was observed in association with the bulbous nuclear cell 212 
region as revealed by staining for neoepitope of MMP-cleaved type I collagen (Fig. 213 
3B, yellow). When cells were plated on top of a 2D layer of collagen fibrils, CORO1C 214 
was similarly found at the cell edge as well as in curvilinear structures forming in 215 
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association with the underlying collagen fibrils, which were positive for the 216 
invadopodia protein TKS5 (Fig. 3C) 8, 40. Collectively, our observations indicated that 217 
CORO1C accumulated at proteolytically active invadopodia forming in association 218 
with confining collagen fibrils.  219 
The effect of GFPCORO1C overexpression on the invasive capacity of MDA-MB-231 220 
cells in 3D collagen was assessed. Multicellular spheroids of MDA-MB-231 cells 221 
overexpressing GFP or GFPCORO1C were formed and embedded in the type I 222 
collagen gel and invasion was monitored after two days. Overexpression of 223 
GFPCORO1C significantly increased the invasive potential of MDA-MB-231 cells in 224 
the 3D collagen gel (Fig. 3DE). CORO1C-dependent invasion required MMP activity 225 
as shown by inhibition in the presence of generic GM6001 MMP inhibitor (Fig. 3E). 226 
The proinvasive potential of CORO1C was generalized using multicellular spheroids 227 
of human MCF10DCIS.com cells overexpressing GFPCORO1C or YFP as a control 228 
(Fig. S3AB). 229 
Actin polymerization is essential for invadopodia formation and function and 230 
CORO1C is known to regulate branched actin dynamics. We therefore investigated 231 
the contribution of CORO1C to the formation of TKS5-positive invadopodia in MDA-232 
MB-231 cells plated on top of a collagen fibril layer as in Fig. 3C. Overexpression of 233 
CORO1C increased significantly the formation of TKS5-positive invadopodia (Fig. 234 
3F). GFPCORO1CR28D/2KE harboring the R28D, K418E, K419E, K427E, and K428E 235 
mutations, which is defective for F-actin binding 41, was diffusely distributed indicating 236 
that CORO1C association to invadopodia required binding to F-actin similar to 237 
CORO1B and -C recruitment to the lamellipodia 41, 42 (Fig. S3C). Remarkably, actin-238 
binding deficient CORO1CR28D/2KE exerted a dominant inhibitory effect on 239 
invadopodia formation (Fig. 3F). An equivalent mutation in CORO1B has been shown 240 
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to affect F-actin binding but no other molecular interactions 15, 42, which may explain 241 
the observed dominant inhibitory potential by titration of important functional partners. 242 
In addition, CORO1C was knocked-down by treatment with two independent siRNAs 243 
leading to >95% silencing of the protein with no effect on MT1-MMP or TKS5 levels 244 
(Fig. S2C). Loss of CORO1C expression reduced by 50-60% the capacity of MDA-245 
MB-231 cells to form TKS5-positive invadopodia in association with the collagen 246 
fibrils (Fig. 3G and Fig. S3DE). CORO1B knockdown similarly decreased the 247 
formation of TKS5-positive invadopodia by ~50% (Fig. 3G and Fig. S2D). Loss of 248 
both CORO1B and -1C did not further reduce invadopodia formation, suggesting that 249 
the two isoforms may function together as recently reported 17 (Fig. 3G). Along this 250 
line, we found that overexpressed CORO1BGFP accumulated together with MT1-251 
MMPmCh in invadopodia forming in association with collagen fibers (Fig. 3H, inset 1 252 
and Fig. S2B). 253 
Consequences of modulation of CORO1C expression on pericellular matrix 254 
degradation in 3D collagen were analyzed by staining of cleaved collagen. Collagen 255 
proteolysis mediated by MT1-MMP was strongly up-regulated upon CORO1C 256 
overexpression, while ECM degradation was inhibited by CORO1CR28D/2KE or 257 
CORO1C silencing (Fig. 3I-K). Collectively, these data indicated that CORO1C had a 258 
significant contribution to invadopodia formation and to the invasive program of 259 
TNBC cells. 260 
We found that CORO1C co-localized with CTTN at invadopodia (Fig. 3A). Using the 261 
same assays, we observed that CTTN knockdown strongly decreased 3D collagen 262 
invasion of MDA-MB-231 multicellular spheroids similar to the silencing of MT1-MMP 263 
and CORO1C (Fig. S4A-C). In addition, knockdown of CTTN also correlated with a 264 
strong reduction of pericellular collagen degradation (Fig. S4DE). Thus we concluded 265 
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that up-regulation of CORO1C expression promoted the invasive potential of TNBC 266 
by favoring the formation of proteolytically active invadopodia and that CORO1B/1C 267 
and CTTN contributed to invadopodia activity suggesting some cooperative function. 268 
CORO1C puncta are observed in association with collagen fibers in breast 269 
tumor cells in vivo. Our data identified CORO1C as a key invadopodia component 270 
of invasive MDA-MB-231 cells. In agreement with CORO1C requirement during 271 
collective invasion by epithelial MCF10DCIS.com breast cancer cells (Fig. S3AB), we 272 
also observed a strong association of GFPCORO1C with TKS5-positive proteolytically 273 
active invadopodia forming in association with collagen fibrils in this cell line (Fig. 274 
S5A-C). Thus, the distribution of GFPCORO1C, which localized to invadopodia in 275 
breast cancer cells was investigated in vivo. We used intravital imaging of mammary 276 
MDA-MB-231 and MCF10DCIS.com cell tumor xenografts to visualize GFPCORO1C 277 
in relation with the tumor ECM microenvironment. MDA-MB-231/GFPCORO1C tumor 278 
xenografts growing in the mammary gland of SCID mice upon fat pad injection were 279 
imaged using 2-photon laser scanning intravital microscopy combined with second 280 
harmonic generation (SHG) to visualize collagen fibrils (Fig. 4A). Accumulations of 281 
GFPCORO1C were visible in tumor cells adjacent to collagen fibers (Fig. 4A-C, arrows 282 
and insets 1-3). These structures were morphologically heterogeneous ranging from 283 
small (submicrometric) puncta (Fig. 4B and insets 1-2) to several μm-long linear 284 
structures similar to curvilinear invadopodia observed in tumor cell lines in vitro (Fig. 285 
4C and inset 3). Contrastingly, intravital imaging of fat pad tumors of MDA-MB-231 286 
cells expressing GFPCORO1CR28D/2KE revealed a diffuse cytosolic distribution of the 287 
actin-binding defective CORO1C variant in tumor xenografts (Fig. 4D and inset 4). 288 
Therefore, similar to our observations in cultured cells, accumulation of CORO1C in 289 
association with collagen fibers in vivo required F-actin binding capacity of CORO1C. 290 
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The distribution of CORO1C was similarly analyzed during the growth and invasion of 291 
MCF10DCIS.com tumor xenograft generated using the intraductal (nipple-) injection 292 
model 43. We and others reported that injection of this cell line into the duct lumen in 293 
SCID mice leads to the formation of DCIS tumor xenografts, which can further 294 
progress into invasive lesions upon BM breaching depending on MT1-MMP activity 2, 295 
43. Stable overexpression of GFPCORO1C did not affect MCF10DCIS.com cell’s 296 
growth in culture (Fig. S5D). Whole-mount and tissue section staining of tumor 297 
xenografts analyzed 4-5 weeks after intraductal injection revealed the presence of 298 
large epithelial tumors growing within the mammary duct system of SCID mice 299 
injected with control or GFPCORO1C-overexpressing MCF10DCIS.com cells (Fig. 300 
S5E, F and H). Tumors presented a necrotic center and some invasive foci of 301 
epithelial cells were visible within the mammary gland stroma (Fig. S5E, arrowhead). 302 
Tumor burden (foci number and size) was increased in mammary glands injected 303 
with GFPCORO1C-overexpressing cells as compared to control MCF10DCIS.com 304 
cells, although differences were not statistically significant 4 to 5-weeks after injection 305 
(Fig. S5F-I). These data suggested that GFPCORO1C-overexpression conferred some 306 
growth advantage to MCF10DCIS.com epithelial tumors. Ductal GFPCORO1C-307 
expressing tumor xenografts were analyzed by intravital 2-photon imaging of GFP 308 
and SHG signals. Intraductal tumors were detected as tumor mass surrounded by a 309 
thick bed of collagen bundles tangential to the duct (Fig. 4EF). Some microinvasive 310 
buds were visible consisting of few GFPCORO1C-overexpressing epithelial cells that 311 
migrated in collective manner within the type I collagen bed (Fig. 4EF and insets 5 312 
and 6). Invasion of GFPCORO1C cells progressed overtime in the collagen-enriched 313 
stroma (compare inset 5 and 6 acquired at 1-week time interval). Intravital imaging at 314 
later time point (7-weeks post injection) revealed frankly invasive tumor lesions (Fig. 315 
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4G-I). The presence of GFPCORO1C accumulations forming at the surface of tumor 316 
MCF10DCIS.com cells in contact with intratumoral collagen fibers was visible similar 317 
to MDA-MB-231 tumors (Fig. 4G-I and inset 7). Collectively, these data indicated that 318 
CORO1C accumulated in structures reminiscent of ECM degradative invadopodia, 319 
which formed in association with collagen fibrils in the invasive breast tumor 320 
xenografts in vivo. 321 
Loss of CORO1C causes MT1-MMP-positive LE/lysosome mispositioning and 322 
collapse. We have shown that MT1-MMP trafficking to invadopodia depends on 323 
actin dynamics on endolysosomes 8, 23. The distribution of GFPCORO1C was analyzed 324 
by live cell imaging by confocal microscopy in MDA-MB-231 cells expressing MT1-325 
MMPmCh. As previously described, MT1-MMPmCh accumulated in vesicles that we 326 
previously identified as LE/lysosomes 7, 32. In addition to GFPCORO1C localization to 327 
lamellipodia, we observed the accumulation of GFPCORO1C in dynamic and discrete 328 
puncta on a majority of MT1-MMPmCh-positive vesicles (Fig. 5A and Supplementary 329 
Movie S2). In contrast, F-actin-binding-deficient GFPCORO1CR28D/2KE was diffuse and 330 
cytosolic (Fig. 5B). Endosomal CORO1C-enriched puncta were also positive for 331 
CTTN, although a slight shift was visible between the localization of the two proteins 332 
in line with the distinct roles played by these proteins in the actin branching cycle 15, 17 333 
(Fig. 5C, inset). Similarly, CORO1BGFP-positive puncta were visible on MT1-MMP 334 
LE/lysosomes (Fig. 3H, inset 2). Cryoimmunoelectron microscopy confirmed the 335 
association of GFPCORO1C-positive puncta on the cytosolic face of LE/lysosomes 336 
(Fig. 5D). All together, these data revealed that CORO1C and CORO1B localized to 337 
endosomal actin-, CTTN-rich puncta, which depend on WASH and Arp2/3 complexes 338 
for their formation and are implicated in MT1-MMP delivery to invadopodia in breast 339 
cancer cells 8, 23, 32, 34, 35. 340 
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We went on analyzing the consequences of CORO1C knockdown on the distribution 341 
and morphology of MT1-MMP-positive LE/lysosomes. In control RNAi treated cells, 342 
MT1-MMP-positive LE/lysosomes were distributed throughout the cell, with a 343 
concentration in the central region of the cell (Fig. 5E and IJ). In cells silenced for 344 
CORO1C, MT1-MMP-positive LE/lysosomes were also predominantly localized to 345 
the cell center (Fig. 5F and I). In addition, we observed that reduced expression of 346 
CORO1C resulted in a tight clustering of MT1-MMP-positive LE/lysosomes in ~70% 347 
of the cells (Fig. 5J). We recently identified the scaffolding proteins JIP4 and JIP3 as 348 
key players in MT1-MMP endosome positioning by linking LE/lysosomes to the 349 
microtubule motors kinesin-1 and dynein/dynactin 32. As previously described 32, 350 
depletion of JIP3 and JIP4 resulted in MT1-MMP endosome dispersion toward the 351 
cell periphery (Fig. 5G and IJ and Fig. S6A). Remarkably, triple knockdown of 352 
JIP3/JIP4 and CORO1C partially restored some level of scattering of MT1-MMP-353 
positive endosomes (Fig. 5H and IJ). All together, these data suggested that tight 354 
clustering of MT1-MMP-positive LE/lysosomes induced upon loss of CORO1C 355 
function required retrograde endosomal trafficking in a JIP3/JIP4-dependent manner. 356 
Cells expressing MT1-MMPmCh were fixed and stained for JIP4 and CTTN, and 357 
fluorescence signal associated with MT1-MMPmCh-positive compartments was 358 
quantified. As previously reported 32, JIP4, which is predominantly cytosolic, was 359 
detected throughout the cytoplasm and in close proximity to CTTN-positive puncta on 360 
the cytosolic face of MT1-MMP endosomes (Fig. 6A and quantification in panels DE, 361 
see also Fig. S6C-C” for lower magnification images). Quantification of fluorescence 362 
signal associated with clustered, enlarged MT1-MMPmCh-positive endosomal 363 
compartments in CORO1C-depleted cells revealed opposite effects on CTTN and 364 
JIP4 association, i.e. CTTN association was diminished, while JIP4 accumulated on 365 
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MT1-MMP compartments as compared to siNT-treated cells (Fig. 6B and DE and 366 
Fig. S6D-E’). Additionally, CTTN knockdown did not alter significantly the association 367 
of JIP4 with endosomal membranes (Fig. 6C and DE and Fig. S6B and FF’). 368 
We noticed that morphological changes observed in CORO1C-depleted cells 369 
including enlargement and perinuclear clustering of LE/Lysosomal compartments 370 
were reminiscent of cellular alterations typical of Niemann-Pick disease type C 371 
(NPC). Indeed, cholesterol-enriched LEs cluster in the perinuclear area, as a 372 
consequence of defective LE/Lysosome traffic and cholesterol clearance in cells of 373 
lysosomal storage disease patients including NPC cells 44. After fixation, MDA-MB-374 
231 cells treated with control siRNA were stained with the fluorescent cholesterol-375 
binding probe filipin and scattered cholesterol-positive LE structures were observed 376 
(Fig. S6G). Treatment of the cells with U18666A, a widely-used amphipathic steroid, 377 
which blocks exit of cholesterol from LE/lysosomes and recapitulates the NPC 378 
phenotype 45, induced tight clustering of cholesterol-laden LE/Lysosomes in the 379 
perinuclear cell region (Fig. S6H). Similarly, LE/Lysosome clusters forming in 380 
CORO1C-depleted cells were strongly enriched for cholesterol indicative of defective 381 
cholesterol exit from the clustered endosomes (Fig. S6IJ). 382 
In order to get further insight at phenotypic alterations of MT1-MMP-positive 383 
compartments induced by loss of CORO1C function, MDA-MB-231 cells knocked 384 
down for CORO1C were analyzed by transmission electron microscopy. Figure 6F 385 
shows the distribution of LE/lysosomes in control cells. CORO1C depletion caused 386 
various morphological alterations of LE/lysosomal compartments, which were 387 
enlarged, aggregated and fused together and accumulated osmiophilic materials 388 
including lamellar inclusions reminiscent of the NPC phenotype (Fig. 6G-I). 389 
Collectively, these data indicated that CORO1C played a key role in MT1-MMP 390 
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LE/lysosome positioning. Loss of CORO1C expression altered the association of 391 
JIP4 (and CTTN) on endosomal membranes resulting in LE/lysosome clumps in the 392 
perinuclear area possibly responsible for deficient recycling and surface-exposure of 393 
MT1-MMP.  394 
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Discussion 395 
Previous findings indicated that CORO1C, a member of the coronin family of highly 396 
conserved F-actin-binding proteins and regulators of branched actin networks, 397 
contributes to invasiveness and metastasis in several cancer types including 398 
glioblastoma, primary effusion lymphoma and TNBC 24, 26-29, 46. In addition, CORO1C 399 
is a biomarker for invasive progression of hepatocellular carcinoma 25. However, our 400 
understanding of the cellular and molecular mechanisms underlying the role of 401 
CORO1C in tumor invasion has remained limited. 402 
Here, we analyzed the expression profile of CORO1C in breast cancer in relation 403 
with MT1-MMP, the protease responsible for pericellular matrix degradation by 404 
carcinoma cells with major implications in the invasive potential and progression of 405 
breast tumors 2, 47, 48. In a panel of cell lines representative of the breast cancer 406 
molecular subtypes 39, CORO1C protein expression was detected mainly in TNBC 407 
cells similar to MT1-MMP 2. CORO1B was broadly expressed irrespective of the 408 
molecular subtypes, while expression of hematopoietic-specific CORO1A was low to 409 
undetectable 16. Based on RT-qPCR analysis of a retrospective cohort of invasive 410 
breast cancers, we found that CORO1C transcript was up-regulated breast cancers 411 
and was associated with hormone receptor-negativity, high grade and metastasis 412 
risk. In addition, co-up-regulation of CORO1C and MT1-MMP also correlated with 413 
significantly higher metastases risk. ‘High CORO1C expression’ was an independent 414 
prognostic factor of breast cancer in multivariate analysis and prognostic significance 415 
of ‘MT1-MMP and CORO1C expression level’ persisted in Cox multivariate 416 
regression analysis. Likewise, IHC analysis of invasive breast cancer TMAs 417 
confirmed the up-regulation of CORO1C in breast carcinoma at the protein level as 418 
compared to normal epithelial tissue. CORO1B mRNA was also up-regulated in a 419 
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breast tumor subset, although with no impact on metastasis-free survival. Similar to 420 
our findings in breast cancer, published data have correlated CORO1C expression 421 
with high-grade gliomas and liver cancers and poor prognosis in stomach cancers 25, 422 
27, 28, while no such correlation has been reported between CORO1B and cancer 423 
progression. In conclusion, our data, which extend a previous analysis of publicly 424 
accessible databases 46, indicate that CORO1C is up-regulated in hormone receptor-425 
negative breast tumors and associates with poor outcome.  426 
Several studies reported that coronins, including CORO1C, regulate lamellipodial 427 
branched actin network and CORO1C activity impinges on cell migration and 428 
invasion by cancer cells including MDA-MB-231 TNBC cells in vitro 28, 29, 46, 49. 429 
Moreover, CORO1C was associated with invasive cell protrusions and has been 430 
implicated in the degradation of the matrix mimic gelatin by human U373 431 
glioblastoma-derived cells 28, 29. In the present study, we observed that CORO1C co-432 
localized with CTTN and TKS5 in matrix-degradative actin-based invadopodia 433 
forming in association with type I collagen fibrils in TNBC cells. Importantly, 434 
knockdown of CORO1C inhibited invadopodia formation, pericellular collagenolysis 435 
and invasive migration in 3D collagen in two TNBC cell models with distinct 436 
mesenchymal (MDA-MB-231) or epithelial (MCF10DCIS.com) features. Thus, our 437 
work indicates that CORO1C is required both for single-cell and collective invasion 438 
patterns. Association of CORO1B with invadopodia was also observed and CORO1B 439 
was required for invadopodia formation. Moreover, loss of both CORO1C and 1B did 440 
not further inhibited invadopodia formation, suggesting that both isoforms may 441 
function as a complex as previously shown 17. 442 
Actin polymerization is a key component of invadopodia-based invasion program by 443 
driving invasive cell protrusions through the matrix and maintaining tight apposition of 444 
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surface-exposed MT1-MMP with confining ECM fibrils 4, 8. In addition, binding of 445 
MT1-MMP cytosolic tail to the invadopodial actin network is thought to anchor MT1-446 
MMP to these structures 50. Assembly of invadopodial actin requires activation of the 447 
Arp2/3 complex by N-WASP 8, 11, 50. An antagonism of CTTN and coronin functions 448 
has been proposed in the control of a cycle of Arp2/3 branch stabilization and 449 
destabilization (15-17, 51 and references herein). In addition, coronin and CTTN have 450 
been implicated in the regulation of cofilin activity in actin filament turnover, which is 451 
crucial during invadopodia assembly 11, 51. We observed that CORO1B/1C and CTTN 452 
co-localized at invadopodia. Alike CORO1B/1C, CTTN has been identified as a key 453 
regulator of invadopodia formation and its overexpression in various cancer types is 454 
associated with tumor progression and metastasis 6, 12. Here, we found that 455 
unbalanced CTTN and CORO1B/1C activity upon individual silencing (or inhibition) of 456 
either proteins impairs invadopodia formation and function, emphasizing complex 457 
and cooperative functions of CTTN and CORO1B/1C in the branching/debranching 458 
cycle to replenish Arp2/3 complex and actin pools to promote invadopodia actin 459 
dynamics and cancer cell invasion. Overall, our data suggest that CORO1B and 460 
CORO1C function together in the mechanism of invadopodia formation and in matrix 461 
remodeling. Yet, the reason for the specific association of CORO1C up-regulation - 462 
and not CORO1B - with cancer aggressiveness is unclear, we cannot rule out some 463 
additional function of CORO1C related to its association with cancer aggressiveness. 464 
Invadopodia’s role in matrix degradation has been experimentally established, 465 
however the existence and physiological relevance of invadopodia in cancer is 466 
questionable because of a lack of direct evidence in vivo. Yet, recent studies 467 
provided convincing evidence that invadopodia formation is essential for 468 
extravasation and intravasation of tumor cells and promotes lung metastasis in mice 469 
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9, 10, 52. Reports based on intravital imaging of tumor cells expressing fluorescently-470 
tagged markers documented the existence of cytoplasmic protrusions identified as 471 
invadopodia based on CTTN, N-WASP or TKS5 enrichment and that correlated with 472 
cancer cell intra- or extravasation in vivo 9, 10. Importantly, intravital imaging of 473 
mammary tumor xenografts of GFPCORO1C-expressing MDA-MB-231 or 474 
MCF10DCIS.com cells revealed the presence of GFPCORO1C accumulations 475 
adjacent to collagen fibers in the tumor microenvironment. However, evidence that 476 
these structures are proteolytically active is lacking and we cannot formally conclude 477 
that GFPCORO1C accumulations represent bona fide invadopodia in vivo. Noticeably, 478 
GFPCORO1C-positive structures were observed both in mesenchymal MDA-MB-231 479 
cells and in strands of invasive epithelial MCF10DCIS.com cells supporting the 480 
implication of CORO1C in mesenchymal and collective invasion programs. 481 
Branched actin networks also exist on intracellular compartments including 482 
endolysosomes where their main function is to sculpt and stabilize endosomal 483 
membrane microdomains involved in cargo sorting and recycling 34, 35, 53. Endosomal 484 
actin patches are nucleated by the Arp2/3-complex upon WASH-mediated activation 485 
34, 35. Earlier on, we found that the WASH complex localizes to MT1-MMP-containing 486 
LE/lysosomes and its function is required for MT1-MMP trafficking to invadopodia 8. 487 
In addition, several groups reported that depletion of WASH led to enlargement and 488 
massive tubulation of the endolysosomal system supporting the idea that WASH-489 
dependent actin assembly may regulate the fission of endosomal recycling tubules 34, 490 
35, 54. CTTN was also found to associate with and regulate endosomal actin puncta on 491 
MT1-MMP-positive LE/Lysosomes, and it was reported that CTTN loss or 492 
deregulation led to the accumulation of enlarged LE/Lysosomes and defective 493 
endosomal traffic 8, 23, 37, 55. The present study provides corroborating evidence that in 494 
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the absence of CORO1C, endolysosomal compartments dramatically enlarged and 495 
collapsed in the perinuclear cell area. It has been argued that deficient cargo exit 496 
exemplified by massive cholesterol accumulation and organelle obstruction may lead 497 
to endosome enlargement 54. Alteration of the endosomal actin coat may induce 498 
endosomal collapse possibly through uncontrolled fusion of individual endosomes. 499 
This assumption is supported by findings that interfering with endosomal actin 500 
regulatory components such as WASH, CTTN, CORO1A or -C lead to perinuclear 501 
redistribution and collapse of endolysosomal compartments 34-37, 54 (this study). 502 
Moreover, we previously found that the related JIP3 and JIP4 scaffolding proteins 503 
regulate the recruitment of minus-end and plus-end microtubule motor complexes to 504 
WASH-positive domains 32. Loss of JIP3 and JIP4 proteins led to the accumulation of 505 
MT1-MMP compartments at the cell periphery indicating unbalanced minus/plus-end 506 
motor activities (at minus-end dynein expense) 32. Here we found that loss of 507 
CORO1C moderately increases JIP3/JIP4 recruitment on MT1-MMP-positive 508 
endosomes although the underlying mechanism remains unknown. Interestingly, 509 
enhanced recruitment of JIP4 to endolysosomal compartments was recently shown 510 
to induce endolysome collapse into the cell center 56. Excess JIP3/JIP4 on MT1-MMP 511 
endosomes is expected to promote their perinuclear accumulation due to increased 512 
dynein activity, possibly favoring endosome collision and collapse. In agreement with 513 
this assumption, we found that formation of endosomal clusters upon loss of 514 
CORO1C was abrogated when JIP3/JIP4 were silenced. Also to be considered, 515 
coordinated functions of coronins and CTTN were also implicated in the regulation of 516 
endolysosome docking with the plasma membrane and exocytosis 37, 38. All together, 517 
our work highlights a molecular framework based on interplay of WASH, CTTN, 518 
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CORO1C and JIP3/JIP4 function in the regulation of endosome positioning and 519 
dynamics as an essential component of MT1-MMP-based metastatic program. 520 
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Materials and Methods 521 
Cell culture. MDA-MB-231 cells (ATCC HTB-26) were grown in L15 medium 522 
supplemented with 15% fetal calf serum and 2 mM glutamine at 37°C in 1% CO2. 523 
MCF10DCIS.com cell line was purchased from Asterand and maintained in DMEM-524 
F12 medium with 5% horse serum. MDA-MB-231 and MCF10DCIS.com cell lines 525 
were checked monthly for mycoplasma contamination using a real-time PCR method 526 
(MYCOPLASMACHECK, GATC Biotech AG). 527 
Stable and transient transfection and siRNA treatment. MDA-MB-231 cells stably 528 
expressing MT1-MMPmCh have been previously described 57. Lentiviral constructs 529 
encoding GFPCORO1C or GFPCORO1CR28D/2KE 41 cloned in pLKO.1 vector have been 530 
described 29. MDA-MB-231 cells expressing GFPCORO1C, GFPCORO1CR28D/2KE, 531 
GFPCORO1C/MT1-MMPmCh, GFPCORO1CR28D/2KE/MT1-MMPmCh and MCF10DCIS.com 532 
cells stably expressing GFPCoro1C were generated by lentiviral transduction as 533 
described 58. pLL7.0-m1B-EGFP construct encoding CORO1BGFP was provided by 534 
J.E. Bear. For transient expression, MDA-MB-231 cells were transfected with plasmid 535 
constructs using AMAXA nucleofection (Lonza). Cells were analyzed by live cell 536 
imaging 24-48 hr after transfection. For knockdown, MDA-MB-231 cells were treated 537 
with the indicated siRNA (50 nM, see Table S1) using Lullaby (OZ Biosciences) and 538 
analyzed 72 hours after treatment. 539 
Antibodies and reagents. Antibodies used for this study are listed in Table S2. 540 
GM6001 (Millipore) was diluted in ethanol and used at a concentration of 40 μM. 541 
Filipin III (stock in DMSO, 0.1 mg/ml μM working concentration) and U18666A (stock 542 
in H20, 10 μM working concentration) were purchased from Sigma. 543 
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Indirect immunofluorescence microscopy. Samples were fixed with 4% 544 
paraformaldehyde, permeabilized with 0.1% Triton X-100, and then incubated with 545 
specific antibodies (see Table S2). For quantification of CTTN or JIP4 on MT1-546 
MMPmCh-containing endosomes, cells were stained with specific antibodies and z-547 
dimension series of images (z-stacks) were acquired with 0.2 µm interval with a wide-548 
field Eclipse 90i Upright Microscope (Nikon) by mean of a piezoelectric motor (Physik 549 
Instrument), a 100x Plan Apo VC 1.4 oil immersion objective and a cooled interlined 550 
charge-coupled device (CCD) camera (CoolSnap HQ2, Roper Scientific). Images 551 
were deconvolved 59, and detection of CTTN or JIP4 on MT1-MMPmCh-containing 552 
endosomes from the median plane of the z-stack was performed using a CellProfiler 553 
pipeline as previously described 23, 60. Briefly, MT1-MMPmCh-containing endosomes 554 
were identified by thresholding and intensity-based watershed; CTTN or JIP4 spots in 555 
a 3-pixel wide neighborhood around each MT1-MMPmCh-positive vesicle were 556 
identified using a Laplacian of Gaussian filter followed by a watershed on the 557 
automatically thresholded image. Finally, the total area of CTTN or JIP4 spots was 558 
normalized over the total of MT1-MMPmCh-positive vesicles. 559 
Live cell spinning disk confocal microscopy. For live cell confocal spinning disk 560 
microscopy, MDA-MB-231 cells stably expressing GFPCoro1C and MT1-MMPmCh or 561 
GFPCORO1CR28D/2KE and MT1-MMPmCh were plated on glass-bottom dishes (MatTek 562 
Corporation) coated with cross-linked gelatin and kept in a humidified atmosphere at 563 
37°C in 1% CO2. Time-series were acquired using a spinning disk microscope 564 
(Roper Scientific) based on a CSU X1 head (Yokogawa) mounted on the lateral port 565 
of an inverted microscope (TE-2000U-Nikon) steered by MetaMorph software and 566 
equipped with a 60x 1.45 NA oil-immersion objective, a Piezzo Z stage (Mat-City-567 
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Lab), a dual output laser launch that included 491- and 561-nm 50-mW DPSS lasers 568 
(Roper Scientific) and a CCD camera (CoolSNAP HQ2). 569 
Analysis of endosome distribution and clustering. For the analysis of the 570 
distribution of MT1-MMPmCh-positive endosomes, a MATLAB software has been 571 
developed to determine the relative position of each endosome to the cell centroid as 572 
previously described 61. 573 
Invadopodia formation assay. Coverslips were layered with 100 µl of a 2.2 mg/ml 574 
solution of acid-extracted type I rat tail collagen (Corning) mixed with AlexaFluor 647-575 
conjugated type I collagen (5% final). After gelling for 3 min at 37°C, the collagen 576 
layer was washed gently in PBS and 1 ml of cell suspension (105 cells/ml) was 577 
added. Cells were incubated for 90 min at 37°C in 1% CO2 incubator, then pre-578 
extracted with 0.5% Triton X-100 in 4% paraformaldehyde in PBS during 90 s and 579 
fixed in 4% paraformaldehyde in PBS for 20 min. Cells were analyzed by 580 
immunofluorescence staining with TKS5 and CTTN antibodies (Table S2), and z-581 
stacks of images were acquired as described above. For quantification of TKS5 582 
associated with curvilinear invadopodia, 5 consecutive planes corresponding to the 583 
plasma membrane in contact with collagen fibers were projected and surface 584 
covered by TKS5 signal was determined using the thresholding command of ImageJ 585 
excluding regions <8 pixels (i.e. <1 µm) to avoid non-invadopodial structures. Surface 586 
covered by TKS5 was normalized to the total cell surface and values normalized to 587 
control cells. 588 
Quantification of pericellular collagenolysis. Cells were trypsinized and 589 
resuspended in 0.2 ml of 2.2 mg/ml ice-cold collagen I solution in 1x MEM, pH 7.5 590 
buffer (2.5 x 105 cells/ml). A 40 µl-drop of the cell suspension in collagen was added 591 
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on a 18-mm diameter glass coverslip and collagen polymerization was induced by 592 
incubation at 37°C for 30 min. Complete medium was added, and the collagen-593 
embedded cells were incubated for 12 hrs at 37°C. Samples were fixed in 4% 594 
paraformaldehyde in PBS at 37°C for 30 min, and incubated with Col1-3/4C antibody 595 
(2.5 µg/ml) for 2 hrs at 4°C, washed extensively with PBS and counterstained with 596 
Cy3-conjugated anti-rabbit IgG antibodies and with DAPI. Image acquisition was 597 
performed with an A1R Nikon confocal microscope with a 40× NA 1.3 oil objective 598 
using high-sensitivity GaASP PMT detector and a 595 ± 50 nm band-pass filter for 599 
red fluorescence detection. Quantification of the degradation spots was performed as 600 
previously described 8. 601 
Electron microscopy. Cells were fixed with 2,5% glutaraldehyde in 0,1M cacodylate 602 
buffer and processed for EPON embedding and ultrathin sections as described 62. 603 
For cryoimmunolabeling, cells were fixed in a mixture of 2% paraformaldehyde and 604 
0.125% glutaraldehyde in a 0.1M phosphate buffer pH7.4 during 48 hrs 62. Ultrathin 605 
sections were prepared with an ultracryomicrotome Leica EM UC7 and underwent 606 
single immunogold labeling with protein A conjugated to 10-nm diameter gold 607 
particles (Cell Microscopy Center, Department of Cell Biology, Utrecht University). 608 
Samples were analyzed with a Tecnai Spirit electron microscope (FEI Company, 609 
Eindhoven Netherlands) and digital acquisitions were made with a QUEMESA CCD 610 
camera (EMSIS GmbH, Münster, Germany). 611 
Statistics and reproducibility. GraphPad Prism (GraphPad Software) was used for 612 
statistical analysis. Sample size was chosen based on estimates from pilot 613 
experiments and our published results such that appropriate statistical tests could 614 
yield significant results. Data were tested for normal distribution using the 615 
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D’Agostino-Pearson normality test and nonparametric tests were applied otherwise 616 
as indicated in the figure legends. Statistical significance was defined as *, P<0.05; 617 
**, P<0.01; ***, P<0.001; ****, P<0.0001; ns, not significant. Relationships between 618 
protein expression and distribution in tumors vs. normal adjacent tissues were 619 
estimated using Two tailed Student’s t-test and Kruskal-Wallis test (for links between 620 
qualitative and quantitative parameters). Metastasis-free survival was determined as 621 
the interval between initial diagnosis and detection of the first metastasis. Survival 622 
distributions were estimated by the Kaplan–Meier method, and the significance of 623 
differences between survival rates were ascertained with the log-rank test. The Cox 624 
proportional hazards regression model was used to assess prognostic significance, 625 
and the results are presented as hazard ratio (HR) and 95% confidence interval (CI). 626 
The following variables were included in the analysis: SBR grade, lymph node status, 627 
macroscopic tumor size, PR status (all the classical variables with a P value under 628 
0.10 in univariate analysis) and CORO1C or combined CORO1C and MT1-MMP 629 
mRNA expression. For animal studies, no animals were excluded from analyses and 630 
no blinding procedure was used. 631 
 632 
See Supplementary Materials and Methods for additional cell lines, western blot 633 
analysis, patient cohort for mRNA analysis, RT-qPCR analysis, patient biopsies for 634 
western blot analysis, Immunohistochemistry analysis of human breast biopsies, 635 
Mammary fat pad and intraductal injections, Mammary imaging window surgical 636 
implantation and near-infrared multiphoton microscopy of mammary tumor 637 
xenografts. 638 
639 
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Figure Legends 917 
Figure 1. Patients displaying high CORO1C and MT1-MMP mRNA expression 918 
have poor outcomes in breast cancer. (A) Whole-cell lysates from human breast 919 
carcinoma cell lines and Jurkat T cells were normalized for protein concentration and 920 
immunoblotted with indicated antibodies. Stratification of breast cancer cell lines in 921 
Normal-like, TNBC, Luminal and HER2 subtypes was according to 39. (B-E) 922 
Expression of the indicated proteins in the different cell lines divided in four subtypes 923 
was normalized to GAPDH level. Protein levels were analyzed in 2 to 3 experiments 924 
for each protein in each cell line and plots correspond to average expression levels ± 925 
SEM in each subtype. (F) Expression of the indicated genes was analyzed by RT-926 
qPCR in 446 mRNA tumor samples. Patients exhibiting high CORO1C mRNA have 927 
reduced MFS (log-rank test using optimal cutoff of 1.52; p=0.00082). Number of 928 
patients in each subgroup is indicated in parenthesis. (G) Correlation between 929 
indicated gene transcripts was analyzed using the Spearman’s rank correlation test 930 
(in bold type). P values are in italics. (H) Patients exhibiting both high CORO1C and 931 
MT1-MMP mRNAs have reduced MFS (log-rank test using optimal cut-off of 1.52 for 932 
CORO1C and 1.30 for MT1-MMP; P=0.00048). 933 
Figure 2. Increased CORO1C expression in invasive breast cancers. (A, B) 934 
CORO1C immunohistochemistry staining on sections of human invasive breast 935 
cancer (IBC) tissue microarray showing adjacent non-neoplastic tissue (Normal) and 936 
representative TNBC and HER2+ breast cancers. (C, D) Semi-quantitative analysis 937 
of CORO1C protein expression by the H-score method comparing adjacent breast 938 
epithelial tissues and carcinoma tissues (C) or in the different subtypes (D). Two 939 
tailed t-test (C); Kruskal-Wallis test (D). 940 
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Figure 3. CORO1C is required for 3D invasion and invadopodia function. (A) 941 
MDA-MB-231 cells expressing GFPCORO1C (green) were embedded in 2.2 mg/ml 942 
fluorescent type I collagen (magenta) and polymerization was induced at neutral pH 943 
at 37°C. Cells were fixed after 12-16 h and stained for cortactin (red). The nucleus is 944 
stained with DAPI (blue). The image is a single optical plane from a z-stack 945 
(Supplementary Movie S1). The low magnification inset is a projection of the z-stack 946 
of images (collagen is omitted). Inset 1 shows separated channels corresponding to 947 
the boxed region. (B) Cells in 3D collagen (magenta) stained for cleaved collagen 948 
neoepitope (Col1-3⁄4C antibody, yellow) and F-actin (blue). DAPI-stained nuclei are 949 
shown in cyan. (C) MDA-MB-231 cells expressing GFPCORO1C (green) were 950 
incubated on a thick layer of fibrous type I collagen (magenta). Curvilinear 951 
invadopodia forming in association with collagen fibrils (cyan) were labeled for TKS5 952 
(red). Insets show separated channels corresponding to the boxed region. (D) 953 
Phalloidin-labeled multicellular spheroids of MDA-MB-231 cells expressing GFP or 954 
GFPCORO1C after 2 days in 3D collagen I (T2). Insets show spheroids immediately 955 
after embedding in collagen (T0). (E) Mean invasion area of multicellular spheroids at 956 
T2 in the presence or absence of GM6001 normalized to mean spheroid area at T0 ± 957 
SEM. n, spheroid number. Two-way ANOVA. (F) Quantification of invadopodia-958 
associated TKS5 signal in MDA-MB-231 cells expressing GFP, GFPCORO1C or 959 
mutant GFPCORO1CR28D/2KE plated on a thick layer of type I collagen as in panel C. Y-960 
axis indicates TKS5 area normalized to total cell area and to mean value in MDA-961 
MB-231 cells (as percentage) ± SEM. n, number of cells analyzed from three 962 
independent experiments. Kruskal-Wallis test. (G) TKS5-positive invadopodia in 963 
MDA-MB-231 cells knocked down for CORO1C, CORO1B or both as in panel F. n, 964 
number of cells analyzed from five (siNT), three (siCORO1C#04 and #08) or two 965 
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(siCORO1B and siCORO1B+C#04) independent experiments. (H) MDA-MB-231 cells 966 
expressing CORO1BGFP (green) and MT1-MMPmCh (red) plated on fibrous type I 967 
collagen (magenta). CORO1B and MT1-MMP colocalize in invadopodia forming in 968 
association with the collagen fibers (inset 1). CORO1B-positive puncta are also 969 
visible on MT1-MMP endolysosomes (inset 2). (I) Representative images of 970 
pericellular collagenolysis detected with Col1-3/4C antibody (black signal in the 971 
inverted images). Nuclei were stained with DAPI (red). (J, K) Collagen degradation 972 
measured by Col1-3/4C neoepitope staining by indicated cell populations normalized 973 
to GFP-expressing (I) or siNT-treated (J) control cells ± SEM; n, number of cells 974 
analyzed from three independent experiments. Data were transformed using the log 975 
transformation y=log(y) to make data conform to normality and analyzed using one-976 
way ANOVA. 977 
Figure 4. In vivo association of CORO1C-positive invadopodia with ECM fibers. 978 
(A-D) Near-infrared multiphoton microscopy images of tumor sections of 8-week-old 979 
fat pad tumor xenografts from MDA-MB-231/GFPCORO1C (panels A to C) or MDA-980 
MB-231/GFPCORO1CR28D/2KE cells (panel D). Collagen fibers detected by second 981 
harmonic generation (SHG, magenta). (G-I) Time-course of the growth and invasion 982 
of MCF10DCIS.com/GFPCORO1C intraductal tumor xenograft monitored by near-983 
infrared multiphoton microscopy 5 to 7-week post injection. All images are single 984 
optical sections from z-stack except in panel G and H, which show maximum 985 
intensity projections of indicated optical planes. Insets are higher magnification of 986 
boxed regions. White arrows point to accumulations of GFPCORO1C in association 987 
with collagen fibers. 988 
Figure 5. Altered MT1-MMP endosome positioning and morphology upon 989 
CORO1C knockdown. (A) Still image from live cell confocal microscopy sequence 990 
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of MDA-MB-231 cells expressing MT1-MMPmCh and GFPCORO1C (see 991 
Supplementary Movie S2). Inset is a high magnification of the boxed region. Bottom 992 
row shows the fluorescence intensity profiles of MT1-MMPmCh and GFPCORO1C 993 
along the dotted line. (B) High magnification of MDA-MB-231 cell expressing MT1-994 
MMPmCh and GFPCORO1CR28D/2KE as in panel A. Fluorescence intensity profiles are 995 
shown. (C) MDA-MB-231 cells expressing MT1-MMPmCh (red) and GFPCORO1C 996 
(green) stained for CTTN (blue). (D) Cryoimmunoelectron microscopy of MDA-MB-997 
231 cells expressing GFPCORO1C. The micrograph shows the localization of 998 
GFPCORO1C on LE/lysosomes (asterisk) visualized with anti-GFP antibodies and 999 
secondary antibodies coupled to 10-nm diameter protein A-gold (arrows). 1000 
Arrowheads point to GFPCORO1C associated with the cytosolic face of the plasma 1001 
membrane. (E-H). Confocal fluorescence microscopy images of MDA-MB-231 cells 1002 
expressing MT1-MMPmCh (red) superimposed with the phase-contrast image (grey). 1003 
Cells are treated with indicated siRNAs. Cell contour is shown with dashed line. (I) 1004 
Distribution of MT1-MMPmCh-positive endosomes in MDA-MB-231 cells treated with 1005 
indicated siRNAs. Mean percentage of MT1-MMP-positive endosomes according to 1006 
their cell center-to-cell periphery position ± SEM from three independent 1007 
experiments. (J) Proportion of MDA-MB-231 cells (%) with juxtanuclear clustered or 1008 
scattered MT1-MMPmCh endosome distribution from four to five independent 1009 
experiments (Fig. S6C-E). 1010 
Figure 6. Knockdown of CORO1C affects the distribution of MT1-MMP-positive 1011 
endolysosomes and JIP4 and CTTN association. (A-C) Indirect 1012 
immunofluorescence analysis of MDA-MB-231 cells expressing MT1-MMPmCh treated 1013 
with indicated siRNAs with CTTN (blue) and JIP4 (green) antibodies. DAPI-stained 1014 
nuclei are shown in cyan. (D, E) CTTN (D) and JIP4 (E) association with the cytosolic 1015 
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face of MT1-MMPmCh-positive endosomes analyzed based on images such as in 1016 
panel A-C, compared with siNT-treated cells ± SEM from three independent 1017 
experiments. n, number of cells analyzed for each population. (F-I) Electron 1018 
microscopy of ultrathin sections of epon-embedded cells treated with indicated 1019 
siRNAs. Notice the large aggregated endolysosomes in CORO1C-depleted cells 1020 
(asterisks). N, nucleus; LE, endolysosome; m, mitochondria. 1021 






